Evidensia, one of the largest veterinary companies in Sweden, has come under scrutiny for charging significantly more for common pet ailments compared to other clinics. The CEO, Marlene Areskog, asserts that their pricing reflects the costs associated with providing advanced care, rather than being driven by profit motives. She emphasizes that their prices are not exorbitant but necessary for maintaining high standards of veterinary care. Areskog highlights that veterinary care is not a one-size-fits-all service, with Evidensia offering specialist-trained veterinarians and advanced medical equipment. She explains that more complex cases are often referred to large animal hospitals that have the necessary resources, differentiating their services from smaller clinics that may lack such competencies. This specialization justifies the higher charges, according to her. When asked if it is fair for prices to vary so widely among veterinarians in Sweden, Areskog defended their business model, stating that each clinic can operate differently and charge based on the level of care provided. She underscores Evidensia's commitment to modern veterinary medicine and the expertise that comes with it, indicating that their elevated prices are a reflection of the quality of care they aim to deliver.